NCT01042457

Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Chulalongkorn University · Academic / Other
• Sex: All
• Age: 16 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

To evaluate therapeutic response to MMF treatment in patients with International Society of Nephrology/Renal Pathology Society (ISN/RPS) class III or IV lupus nephritis. Mycophenolic acid levels at 1-hour post dose will be monitored monthly up to 6 months.

Conditions

• Lupus Nephritis

Interventions

Type	Name	Description
DRUG	Mycophenolate mofetil	Drug : Mycophenolate Mofetil. Starting doses : 1000-1500 mg/day with titration based on Mycophenolic 1-hour post dose level.

Timeline

• Start date: 2009-05-01
• Primary completion: 2011-12-01
• Completion: 2011-12-01
• First posted: 2010-01-05
• Last updated: 2013-09-30

Locations

1 site across 1 country: Thailand